Viewing Study NCT06972732


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-01-01 @ 9:45 AM
Study NCT ID: NCT06972732
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2025-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Sponsor: Boryung Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module